These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9543466)

  • 41. Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer's disease.
    Ringman JM; Cummings JL
    Expert Opin Investig Drugs; 1999 Apr; 8(4):463-71. PubMed ID: 15992092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment.
    Dingemanse J; Halabi A; Kleinbloesem CH; Heinig R; Blume H
    Ther Drug Monit; 1999 Jun; 21(3):310-6. PubMed ID: 10365643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease.
    Disterhoft JF; Oh MM
    J Physiol Paris; 2006; 99(2-3):180-92. PubMed ID: 16458491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cholinesterase inhibitors on attention.
    Pepeu G; Giovannini MG; Bracco L
    Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
    Hinz V; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats.
    Riekkinen P; Schmidt B; Riekkinen M
    Eur J Pharmacol; 1997 Mar; 323(1):11-9. PubMed ID: 9105871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of metrifonate on memory impairment and cholinergic dysfunction in rats.
    Itoh A; Nitta A; Katono Y; Usui M; Naruhashi K; Iida R; Hasegawa T; Nabeshima T
    Eur J Pharmacol; 1997 Mar; 322(1):11-9. PubMed ID: 9088864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metrifonate.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Dec; 11(6):490-6. PubMed ID: 9413706
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro effects of metrifonate on neuronal amyloid precursor protein processing and protein kinase C level.
    Pakaski M; Rakonczay Z; Fakla I; Papp H; Kasa P
    Brain Res; 2000 Apr; 863(1-2):266-70. PubMed ID: 10773217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metrifonate, like acetylcholine, up-regulates neurotrophic activity of cultured rat astrocytes.
    Mele T; Jurič DM
    Pharmacol Rep; 2014 Aug; 66(4):618-23. PubMed ID: 24948063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metrifonate alters antioxidant levels and caspase activity in cerebral cortex of Wistar rats.
    Pohanka M; Novotny L; Pikula J
    Toxicol Mech Methods; 2011 Oct; 21(8):585-90. PubMed ID: 21943232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metrifonate for Alzheimer's disease patients.
    Schneider LS
    J Clin Psychiatry; 2000 Mar; 61(3):218-9. PubMed ID: 10817111
    [No Abstract]   [Full Text] [Related]  

  • 53. Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats.
    Riekkinen P; Schmidt B; Stefanski R; Kuitunen J; Riekkinen M
    Eur J Pharmacol; 1996 Aug; 309(2):121-30. PubMed ID: 8874130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transformation and action of metrifonate.
    Nordgren I; Bergström M; Holmstedt B; Sandoz M
    Arch Toxicol; 1978 Oct; 41(1):31-41. PubMed ID: 718420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and pharmacodynamics of metrifonate in humans.
    Unni LK; Womack C; Hannant ME; Becker RE
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):285-9. PubMed ID: 8051989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metrifonate and tacrine: a comparative study on their effect on acetylcholine dynamics in mouse brain.
    Nordgren I; Karlén B; Kimland M
    Pharmacol Toxicol; 1992 Sep; 71(3 Pt 1):236-40. PubMed ID: 1438050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study.
    Becker RE; Colliver JA; Markwell SJ; Moriearty PL; Unni LK; Vicari S
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):54-7. PubMed ID: 9539412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate.
    Riekkinen M; Schmidt BH; Riekkinen P
    Eur J Pharmacol; 1997 Nov; 338(2):105-10. PubMed ID: 9455990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metrifonate. Summary of toxicological and pharmacological information available.
    Holmstedt B; Nordgren I; Sandoz M; Sundwall A
    Arch Toxicol; 1978 Oct; 41(1):3-29. PubMed ID: 363095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA.
    Mohammed AH
    Acta Neurol Scand Suppl; 1993; 149():13-5. PubMed ID: 8128832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.